Deep Intelligence Across Industries

Company Headquarters: Herzliya, Israel Founded: 1994 Workforce: ~200 Company Working: Canndoc is a manufacturer of pharma-grade medical cannabis products for more than 13 years. In September 2018, Canndoc was acquired by InterCure (Israel), a medical device company focused on respiratory treatment; in the last 13 years, the company provided millions of doses to 40,000 patients. It has significant expertise in research, cultivation and processing, product development, and advanced GMP clinical trials pipeline initiation. Canndoc provides Good Manufacturing Practice (GMP) pharma-grade cannabis solutions to the patients for their health and treatment outcomes. Canndoc expanded its global production and distribution capabilities by making commercial agreements and joint ventures in Europe and Canada. Its proprietary genetic bank involves more than thirty unique cannabinoid profiles. The company has a presence in Canada, the UK, Portugal, Denmark, Germany, and Israel.

Company Headquarter: Nevada, US Founded: 2001 Workforce: ~50 Company Working: GB Sciences, Inc. is a phytomedicine research and biopharmaceutical drug development company that converts the cannabis plant into medicines, therapies, and treatment-based drugs. The company’s novel drug development pipeline is built through collaborations with top university researchers and industry leaders in novel delivery and manufacturing processes. It operates numerous subsidiaries such as Growblox Life Sciences LLC (US), Growblox Sciences Puerto Rico LLC (US), GB Sciences Las Vegas, LLC (US), and GB Sciences Nevada, LLC (US).

Company Headquarter: Connecticut, US Founded: 2004 Workforce: ~50 Company Working: Cara Therapeutics, Inc. is an emerging biotechnology company that develops novel therapeutics to treat pain, inflammation, and pruritus. It is a clinical-stage biotechnology company working on cannabinoid receptors to develop alternative treatment solutions for patients. The company’s advanced patented compound CR845 is undergoing various clinical tests for uremic pruritus and acute pain. Cara Therapeutics, Inc. has a group of medical experts, scientists, and industry leaders helping in providing innovative solutions to patients.

Company Headquarter: Edmonton, Canada Founded: 2006 Workforce: ~2,800 Company Working: Aurora Cannabis Inc. is a world-renowned integrated cannabis company, a pioneer in medical cannabis, and has an industry-leading reputation for continuously elevating and setting the cannabis industry standard worldwide. The company’s products are helping to improve the health, wellness, and overall quality of life of people. It offers various range of premium quality hemp and cannabis products and services. Its product range involves dried flowers, cannabis oil, edibles, vapes, concentrates, and accessories. Its products are manufactured with EU GMP quality standards. It has three product brands involving CanniMed, Aurora, and MedReleaf. The company operates through a wide range of subsidiaries, including CanvasRx (Canada), Pedanios GmbH (Germany), MedReleaf (Austalia), Reliva, LLC (US), and Aurora Deutschland GmbH (Germany). The firm has a strong presence in Australia, Brazil, Columbia, Denmark, Germany, Italy, Malta, South Africa, and Canada.

Company Headquarter: Ontario, Canada Founded: 2013 Workforce: ~1800 Company Working: Tilray Brands, Inc. (Tilray) engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company is focusing on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: cannabis and hemp. The cannabis segment sales consist of adult-use, medical, and bulk sales of cannabis under-regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to the patient. The hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD sold in an unlicensed operation and sold to retail, wholesale, and direct to consumers. It is a GMP-certified medical cannabis producer, which supplies cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments, and researchers on five continents. Its subsidiaries include Manitoba Harvest (Canada), High Park Company (Canada), Tilray Australia & New Zealand, Tilray Canada, Tilray Europe, and Tilray Latin Americas. In 2018, the company created a Medical Advisory Board, which guides its clinical trial selection process and product development initiatives. It has seven production and processing facilities, including one in Portugal, three cultivation sites in Ontario & British Columbia, and three processing facilities in Manitoba & Ontario. In May 2021, Tilray and Aphria Inc. (Canada) announced their merger in an all-stock deal. The company is directly present in more than 10 countries and has a strong presence in all the established markets such as North Americas, Europe, Africa, and Australia. It also focuses on the research and development of innovative products and spends a significant amount of revenue on R&D

Company Headquarter: Nevada, US Founded: 2005 Workforce: ~50 Company Working: Cannabis Sativa, Inc. has operations in three divisions: telemedicine, contrast manufacturing, and brand development & marketing of products and services in the CBD and marijuana industries. It operates through its subsidiaries, including Wild Earth Naturals (US), White Rabbit (India), hi Brands International (US), Presto Doctor (US), and iBudtender (Canada). It offers products and services to both businesses and consumers and is a publicly-traded company listed as OTCQB: CBDS. The company’s main operations run through its 51% owned telehealth subsidiary PrestoDoctor. PrestoDoctor is a proprietary online telemedicine platform that gives customers access to physicians to obtain a recommendation for medical marijuana.

Company Headquarters: UK, Europe Founded: 2013 Workforce: 500 Company Working: BenevolentAI is a clinical-stage AI-enabled drug discovery and development company. Through the combined capabilities of its AI platform, scientific expertise, and web-lab facilities, Benevolent AI is well-established to deliver novel drug candidates with a higher probability of clinical success. Moreover, BenevolentAI powers a growing in-house pipeline of 13 named drug programmers, and it maintains collaboration with AstraZeneca (UK), as well as research and charitable institutions. The company offers its services under the category of pipeline, COVID-19, atopic dermatitis, and ulcerative colitis as well as company has a strong market presence in Europe.

Company Headquarters: Toronto, Canada Founded: 2013 Workforce: 200 Company Working: Cyclica is a data-driven drug discovery company. The company’s calculation method for polypharmacology is unique in the industry. Cyclica used a proteome-wide lens to measure novel and off-target interaction instantaneously. The company offers its product and services under the category of drug development, network pharmacology, drug repositioning, proteomics, clinical trials, side effects, bioinformatics, systems biology, drug discovery, artificial intelligence, polypharmacology, medicines, machine learning, pharmacology, pharmaceuticals, and bioinformatics. The company has a strong business presence in Canada.

Company Headquarters: Hong Kong, China Founded: 2014 Workforce: 200 Company Working: Insilico Medicine is a technology company specializing in drug discovery and drug development processes. It offers products under the category of pharma.AI suite, pandaomics, chemistry42, and inclinico. The company is dedicated to expanding human productive longevity and transforming every step of the drug discovery and drug development process by best practices in biomarker discovery, drug development, digital medicine, and aging research. The company has a strong business presence in the US, China, Canada, UAE, Belgium, the UK, and Taiwan.